Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arctium lappa flavone extract is a bioactive fraction derived from the roots of *Arctium lappa* (commonly known as Burdock), specifically processed to enrich for flavonoid content. This extract has been primarily investigated for its potential in treating atherosclerosis and hyperlipidemia. Research, particularly in avian models like quails, suggests that the flavone extract possesses significant antioxidant properties, enhancing the activity of endogenous enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) while reducing lipid peroxidation markers like malondialdehyde (MDA). Additionally, it demonstrates lipid-lowering effects by reducing serum total cholesterol, triglycerides, and low-density lipoprotein cholesterol (LDL-C), thereby exerting a protective effect against high-fat diet-induced vascular damage and plaque formation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on arctium lappa flavone extract.